Elsamicin a or elsamitrucin
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281612This classification denotes a topoisomerase-ii inhibitor and miscellaneous antineoplastic antibiotic with the molecular formula C33H35NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZTV0FOB6NU, chemically known as 2-amino-2,6-dideoxy-3-o-methyl-d-galactose but generally known as elsamitrucin, which bears US NIH Compound Identifier 5362259. European Medicines Agency schedules Elsamitrucin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06493MIG. The term ELSAMITRUCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). ELSAMITRUCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Elsamicin a or elsamitrucin bears US NLM identifiers UMLS ID C0059041 and NCI Concept Code C1080. SMILES: O(C1C(O)(C(O)C(OC1OC1C2C(C(O)C3C4C2OC(=O)C2C4C(OC3=O)CCC2C)CCC1)C)C)C1OC(C(O)C(OC)C1N)C.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.